Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 18
Page 291
... azathioprine- and placebo - treated patients ( modified with permission from Ref . 10 ) ( 12 week ) benefit of azathioprine on the outcome of remission ( CDAI < 175 ) . However , at the termination of the trial ( 15 months ) there was a ...
... azathioprine- and placebo - treated patients ( modified with permission from Ref . 10 ) ( 12 week ) benefit of azathioprine on the outcome of remission ( CDAI < 175 ) . However , at the termination of the trial ( 15 months ) there was a ...
Page 296
... azathioprine experienced a relapse of disease , compared with 20 of 34 ( 59 % ) of placebo - treated patients ( p = 0.04 ) ( Figure 6 ) . Three azathioprine- treated patients developed transient bone marrow suppression which required a ...
... azathioprine experienced a relapse of disease , compared with 20 of 34 ( 59 % ) of placebo - treated patients ( p = 0.04 ) ( Figure 6 ) . Three azathioprine- treated patients developed transient bone marrow suppression which required a ...
Page 303
... azathioprine in patients with colitis . The only trial which has evaluated methotrexate for this indication failed ... azathioprine in Crohn's disease . Lancet . 1971 ; 2 : 944–7 . 6. Rosenberg JL , Levin B , Wall AJ , Kirsner JB . A ...
... azathioprine in patients with colitis . The only trial which has evaluated methotrexate for this indication failed ... azathioprine in Crohn's disease . Lancet . 1971 ; 2 : 944–7 . 6. Rosenberg JL , Levin B , Wall AJ , Kirsner JB . A ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis